- Recommendation ID
- NG245/3
- Question
What is the cost-effectiveness and feasibility of the proposed BTS/NICE/SIGN diagnostic pathways for asthma in children and young people aged 5 and over and in adults aged 17 and over?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale and impact section on objective tests for diagnosing asthma in adults, young people and children aged 5 to 16 with a history suggestive of asthma .
Full details of the evidence and the committee's discussion are in:
evidence review A: diagnostic test accuracy of spirometry in people suspected of asthma
evidence review B: diagnostic test accuracy for bronchodilator reversibility in people suspected of asthma
evidence review C: diagnostic test accuracy of peak expiratory flow variability for the diagnosis of asthma
evidence review D: accuracy of skin prick test in children for the diagnosis of asthma
evidence review E: diagnostic test accuracy of IgE in children
evidence review F: diagnostic accuracy of fractional exhaled nitric oxide (FeNO) measures
evidence review G: diagnostic accuracy of eosinophil blood count measures in the diagnosis of asthma
evidence review H: bronchial challenge with histamine and methacholine for the diagnosis of asthma
evidence review I: bronchial challenge test with mannitol
evidence review J: bronchial challenge testing in response to exercise for the diagnosis of asthma
evidence review K: diagnostic accuracy of combination of tests.
Source guidance details
- Comes from guidance
- Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)
- Number
- NG245
- Date issued
- November 2024
Other details
Is this a recommendation for the use of a technology only in the context of research? | No |
Is it a recommendation that suggests collection of data or the establishment of a register? | No |
Last Reviewed | 28/01/2025 |